(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Famous Rough terrain Vehicles for 2024 - 2A rare whale is having an encouraging season for births. Scientists warn it might still go extinct
- 3Instructions to Utilize the Towing Highlights of the Slam 1500 Productively.
- 4Texas cities have some of the highest preterm birth rates in the US, highlighting maternal health crisis nationwide
- 5AI’s errors may be impossible to eliminate – what that means for its use in health care
- True serenity: Investigating Emotional well-being and the Advantages of Contemplation
- 'I carried my wife's body for an hour and a half' - BBC hears stories of protesters killed in Iran
- ‘Integral part of our nation’: Herzog visits Franciscan Sisters in Jerusalem ahead of Christmas
- US FDA declines to approve Corcept's drug for rare hormonal disorder
- Instructions to Upgrade the Security Elements of Your Kona SUV
- PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds
- Simple Consideration Plants for Home and Office: An Aide
- Step by step instructions to Figure out the Natural Effect of 5G Pinnacles
- The Ursid meteor shower will be the last of the year, peaking just before Christmas: What to know and how to watch
